Cite
HARVARD Citation
Furihata, K. et al. (2021). A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis. Clinical pharmacology in drug development. 10 (8), pp. 870-883. [Online].